Accelerated Development Pathways for Biopharmaceutlcals: Will Your CMC Package Be Submission Ready?

摘要

In recent years,both the US and the EU have streamlined their regulatory oversight and approval processes to allow for the expedited review and approval of biopharmaceuticals.